(19R)-3-ETHYL-N-((1R)-1-(2-(5-((1-ETHYLPYRAZOL-4-YL)METHYL)-2-METHYLTRIAZOL-4-YL)-5-FLUOROPHENYL)ETHYL)-16-FLUORO-10,19-DIMETHYL-20-OXA-3,4,9,10,11,23-HEXAZAPENTACYCLO(19.3.1.02,6.08,12.013,18)PENTACOSA-1(25),2(6),4,8,11,13(18),14,16,21,23-DECAEN-22-AMINE
UNII EE7Y7LVK8C
Substance Identification & Data
This profile provides standardized clinical and technical data for (19r)-3-ethyl-n-((1r)-1-(2-(5-((1-ethylpyrazol-4-yl)methyl)-2-methyltriazol-4-yl)-5-fluorophenyl)ethyl)-16-fluoro-10,19-dimethyl-20-oxa-3,4,9,10,11,23-hexazapentacyclo(19.3.1.02,6.08,12.013,18)pentacosa-1(25),2(6),4,8,11,13(18),14,16,21,23-decaen-22-amine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EE7Y7LVK8C.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C39H40F2N12O MRTOOWJEZMRGPG-DHIUTWEWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (19r)-3-ethyl-n-((1r)-1-(2-(5-((1-ethylpyrazol-4-yl)methyl)-2-methyltriazol-4-yl)-5-fluorophenyl)ethyl)-16-fluoro-10,19-dimethyl-20-oxa-3,4,9,10,11,23-hexazapentacyclo(19.3.1.02,6.08,12.013,18)pentacosa-1(25),2(6),4,8,11,13(18),14,16,21,23-decaen-22-amine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.